Curis (CRIS) Reports IND Filing for Erivedge Phase 2
Tweet Send to a Friend
Curis, Inc. (Nasdaq: CRIS) announced that Roche (OTCBB: RHHBY) has filed an Investigational New Drug (IND) application with the U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE